Xtuit Pharmaceuticals

formerly XtuitClosed

Targeting the tumor microenvironment to overcome cancer drug resistance

Waltham, United States · Founded 2011 · $26.0M raised

Employees
11–50
Founded
2011
Business Model
B2B
Website
xtuit.com
Total Funding
$26.0M
Last Round
$22.0M Series AJun 2015
Rounds
3

About

XTuit Pharmaceuticals was a biopharmaceutical company developing novel microenvironment-activated therapeutics that targeted key mechanisms driving tumor hypoxia, decreased drug uptake, drug resistance, and diminished immune response. Founded in 2011 by Harvard professor Rakesh Jain, MIT professor Robert Langer, and Polaris Partners' Alan Crane, the Waltham, Massachusetts-based company focused its pipeline on the tumor microenvironment before ceasing operations after its last funding round in September 2016.

Summary

Xtuit Pharmaceuticals is a Biotech company based in Waltham, United States, founded in 2011. It has raised $26.0M in total across 3 rounds, most recently a $22.0M Series A round in Jun 2015. Investors include Polaris Partners, New Enterprise Associates and Arcus Ventures.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AJun 2015
$22.0M

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Xtuit Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/xtuit-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/xtuit-pharmaceuticals" alt="Xtuit Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>